Advanced search
Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 17, 2005 - Issue 7
Submit an article Journal homepage
80
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Recreational substance use and tolerance of efavirenz in HIV-1 infected patients

F. Faggian Infectious Diseases Unit, ‘Civile Maggiore’ Hospital, and Section of Infectious Diseases, Department of Pathology, University of Verona, Verona, Italy
,
E. Lattuada Infectious Diseases Unit, ‘Civile Maggiore’ Hospital, and Section of Infectious Diseases, Department of Pathology, University of Verona, Verona, Italy
,
M. Lanzafame MD Infectious Diseases Unit, ‘Civile Maggiore’ Hospital, and Section of Infectious Diseases, Department of Pathology, University of Verona, Verona, ItalyCorrespondence[email protected]
,
D. Antolini Infectious Diseases Unit, ‘Civile Maggiore’ Hospital, and Section of Infectious Diseases, Department of Pathology, University of Verona, Verona, Italy
,
E. Concia Infectious Diseases Unit, ‘Civile Maggiore’ Hospital, and Section of Infectious Diseases, Department of Pathology, University of Verona, Verona, Italy
&
S. Vento Infectious Diseases Unit, ‘Civile Maggiore’ Hospital, and Section of Infectious Diseases, Department of Pathology, University of Verona, Verona, Italy
Pages 908-910 | Published online: 18 Jan 2007

References

  • Bristol-Myers Squibb Company (2002) . Sustiva product information . Princeton , NJ : Bristol-Meyers Squibb Company .
  • Carr , A. 2004 . Antiretroviral therapy for previously untreated HIV-1 infected adults: 2NN, or just one? . Lancet , 363 : 1248 – 1250 .
  • Harrington , R.D. 1999 . Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate . Archives of Internal Medicine , 159 : 2221 – 2224 .
  • Henry , J.A. and Hill , I.R. 1998 . Fatal interaction between ritonavir and MDMA . Lancet , 352 : 1751 – 1752 .
  • Hirscel , B. 2002 . Switching from protease inhibitors to efavirenz: Differences in efficacy and tolerability among risk groups. A case control study from the Swiss HIV cohort . AIDS , 16 : 381 – 385 .
  • Montaner , J.S.G. , et al. (2002) . FOCUS study: Saquinavir QD regimen versus efavirenz QD regimen 48-week analysis in HIV infected patients . 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy , September , San Diego .
  • Perez-Molina , J.A. 2002 . Safety and tolerance of efavirenz in different antiretroviral regimens: Results from a National Multicenter Prospective Study in 1,033 HIV-infected patients . HIV Clinical Trials , 3 : 279 – 286 .
  • Staszewski , S. 1999 . Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-infection in adults . New England Journal of Medicine , 341 : 1865 – 1873 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.